Biostage, Inc.
(Other OTC/NBB : HART)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.15%197.151.2%$609.08m
GILDGilead Sciences, Inc.
-0.15%67.910.9%$502.48m
CELGCelgene Corporation
-3.03%67.301.2%$478.41m
BIIBBiogen Inc.
0.38%320.431.3%$469.39m
ILMNIllumina, Inc.
0.10%301.903.5%$382.10m
REGNRegeneron Pharmaceuticals, Inc.
-0.03%338.892.6%$298.58m
VRTXVertex Pharmaceuticals Incorporated
-0.54%160.201.9%$259.14m
ALXNAlexion Pharmaceuticals, Inc.
1.76%117.082.0%$202.57m
AAgilent Technologies, Inc.
7.78%67.481.5%$200.45m
SRPTSarepta Therapeutics, Inc.
1.54%118.1615.4%$149.04m
LGNDLigand Pharmaceuticals Incorporated
1.70%151.0623.3%$141.94m
EXASExact Sciences Corporation
-3.48%64.9425.3%$132.25m
TSROTESARO, Inc.
15.23%42.4414.4%$126.05m
NKTRNektar Therapeutics
0.63%38.255.6%$123.02m
INCYIncyte Corporation
-0.81%63.732.5%$114.80m

Company Profile

Biostage, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. The company was founded on May 3, 2012 and is headquartered in Holliston, MA.